Shionogi's Xocova Extends Global Reach Through First MPP Sublicenses

 
• By Lisa Takagi
  
Xocova's sublicensing deal suggests its global debut may come earlier than the original product.
Xocova's sublicensing deal to provide drug in 117 low- and-middle-income countries. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip